Obesity
📧 Sign up to get email alerts when something new happens for Obesity.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-02-04Clinical Trial Update: Efficacy and Safety of GZR18 Every 2 Weeks Versus Tirzepatide and Placebo in Obese or Overweight Participants [Phase 2]
A Phase 2 trial comparing GZR18 every two weeks to tirzepatide and placebo in adults who are obese or overweight, assessing efficacy and saf…
-
CLINICAL_TRIALS trial_result · 2025-01-31Clinical Trial Update: Lifestyle Behavior Weight Loss Intervention [NA]
This document reports the completion of a clinical trial evaluating a lifestyle behavior weight loss intervention for obesity. Results were …
-
CLINICAL_TRIALS trial_result · 2025-01-31Clinical Trial Update: Impact of Weight Loss Induced by Bariatric Surgery or Nutritional Management on Sexual Function in Men With Severe Obesity
This clinical trial investigates how weight loss from bariatric surgery or nutritional management affects sexual function in men with severe…
-
CLINICAL_TRIALS trial_result · 2025-01-29Clinical Trial Update: The Cardiac Effects of Empagliflozin in Patients With High Risk of Heart Failure [Phase 2]
Phase 2 trial update evaluating the cardiac effects of empagliflozin in patients at high risk of heart failure. The study status is complete…
-
CLINICAL_TRIALS trial_result · 2025-01-29Clinical Trial Update: The Metabolic Effects of Empagliflozin in Patients With High Risk of Heart Failure [Phase 2]
Phase 2 trial assessing the metabolic effects of empagliflozin in patients with obesity at high risk of heart failure has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-01-29Clinical Trial Update: IL-1-receptor Antagonist During Cephalic Phase of Insulin Secretion in Health and Type 2 Diabetes [Phase 2]
A Phase 2 trial of an interleukin-1 receptor antagonist evaluating cephalic-phase insulin secretion in healthy individuals and people with T…
-
CLINICAL_TRIALS trial_result · 2025-01-29Clinical Trial Update: Effects of Berberine in Reducing Abdominal Visceral Adipose Tissue Among Individuals with Obesity and NAFLD [Phase 4]
Phase 4 study evaluating berberine for reducing abdominal visceral adipose tissue in individuals with obesity and NAFLD has completed.
-
CLINICAL_TRIALS trial_result · 2025-01-28Clinical Trial Update: Effect of the Probiotic SF68® on Body Composition and Low-to-moderate Cardiovascular Risk [NA]
A completed clinical trial evaluating the probiotic SF68® for effects on body composition and cardiovascular risk in individuals with overwe…
-
CLINICAL_TRIALS trial_result · 2025-01-28Clinical Trial Update: Effectiveness of the Croq'Santé Nutrition Education Program in Improving Food Literacy in Schoolchildren [NA]
A completed clinical trial evaluating the effectiveness of the Croq'Santé nutrition education program in improving food literacy among schoo…
-
CLINICAL_TRIALS trial_result · 2025-01-28Clinical Trial Update: Healthy Me: A Program for Older Women [NA]
Duke University reports that the Healthy Me: A Program for Older Women trial addressing obesity has completed.
-
CLINICAL_TRIALS trial_result · 2025-01-27Clinical Trial Update: Study for Multiple Doses of HM15136(Efpegerglucagon) in Obese or Overweight Subjects With Comorbidities [Phase 1]
Phase 1 study evaluating multiple doses of HM15136 (Efpegerglucagon) in obese or overweight adults with comorbidities has completed and resu…
-
CLINICAL_TRIALS trial_result · 2025-01-27Clinical Trial Update: A Study of Multiple Doses of HM15211(Efocipegtrutide) in Obese Subjects With NAFLD [Phase 1]
Phase 1 study evaluating multiple-dose Efocipegtrutide (HM15211) in obese subjects with non-alcoholic fatty liver disease has completed, wit…
-
CLINICAL_TRIALS trial_result · 2025-01-27Clinical Trial Update: Walking Training Improves Thyroid and Cardiometabolic Markers in Postmenopausal Obesity [NA]
A completed clinical trial shows that walking training improves thyroid-related markers and cardiometabolic risk factors in postmenopausal o…
-
CLINICAL_TRIALS trial_result · 2025-01-24Clinical Trial Update: Comparing Objective and Subjective Physical Activity Assessments in Obese Patients
This completed clinical trial compares objective versus subjective physical activity assessments in obese patients.
-
CLINICAL_TRIALS trial_result · 2025-01-23Clinical Trial Update: A 16-Week Study to Evaluate the Efficacy, Safety, and Tolerability of GLY-200 in Participants With Obesity [Phase 2]
Phase 2 study completed evaluating GLY-200 in adults with obesity, reporting on efficacy, safety, and tolerability over 16 weeks.
-
CLINICAL_TRIALS trial_result · 2025-01-23Clinical Trial Update: The Effects of Psyllium Seed on Body Weight and Metabolic Syndrome Indicators in Patients with Schizophrenia [NA]
A completed clinical trial evaluated the effects of psyllium seed on body weight and metabolic syndrome indicators in overweight or obese pa…
-
CLINICAL_TRIALS trial_result · 2025-01-23Clinical Trial Update: Pleasure for Food and Endocannabinoids in Obesity [NA]
A clinical trial sponsored by INSERM examining obesity and endocannabinoids related to food pleasure has completed.
-
CLINICAL_TRIALS trial_result · 2025-01-23Clinical Trial Update: Evaluation of an Anti-inflammatory Diet in Autoimmune and Metabolic Diseases [NA]
A clinical trial evaluating an anti-inflammatory diet in people with Type 1 diabetes and obesity has completed, according to sponsor IRCCS S…
-
CLINICAL_TRIALS trial_result · 2025-01-22Clinical Trial Update: Study to Evaluate ARD-101 in Adults With Obesity [Phase 2]
This update reports the completion of a Phase 2 trial evaluating ARD-101 for obesity and that trial results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-01-22Clinical Trial Update: Outcome of Combined Botulinum Toxin A Injection and Gastric Balloon Implantation in Obesity Treatment [Phase 2, Phase 3]
The trial reports the outcomes of a combined botulinum toxin A injection and gastric balloon implantation for obesity, with Phase 2 and Phas…
-
CLINICAL_TRIALS trial_result · 2025-01-22Clinical Trial Update: A Study in People With Overweight or Obesity to Test How Well Different Doses of BI 1820237 Are Tolerated When Given Alone or in Combination With Either Semaglutide or BI 456906 [Phase 1]
A Phase 1 study completed in overweight/obesity participants evaluating tolerability of BI 1820237 given alone or with Semaglutide or BI 456…
-
CLINICAL_TRIALS trial_result · 2025-01-20Clinical Trial Update: An Integrative Study of the Role of Microbiome, Metabolome, Transcriptome and Chronobiology in the Context of Type 2 Diabetes.
Completed clinical trial evaluating how the microbiome, metabolome, transcriptome, and chronobiology relate to Prediabetes and Type 2 Diabet…
-
CLINICAL_TRIALS trial_result · 2025-01-20Clinical Trial Update: A Study to Learn How Different Amounts of the Study Medicine Danuglipron Are Taken up Into the Blood in Otherwise Healthy Adults With Overweight or Obesity [Phase 1]
Phase 1 pharmacokinetic study to determine how different doses of Danuglipron are absorbed into the bloodstream in otherwise healthy adults …
-
CLINICAL_TRIALS trial_result · 2025-01-20Clinical Trial Update: Hydrogen-rich Water and Appetite in Obesity [NA]
Completed clinical trial from the University of Novi Sad on hydrogen-rich water and appetite in obesity.
-
CLINICAL_TRIALS trial_result · 2025-01-17Clinical Trial Update: Molecules Associated with Pediatric Obesity
This is a completed clinical trial update investigating molecules associated with pediatric obesity.